Chargement en cours...
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Adjuvant chemotherapy for non-small-cell lung carcinoma (NSCLC) is a debated issue in clinical oncology. Although it is considered a standard for resected stage II-IIIA patients according to the available guidelines, many questions are still open. Among them, it should be acknowledged that the treat...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3284429/ https://ncbi.nlm.nih.gov/pubmed/22206620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-115 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|